Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world. Since 1898, our doctors and scientists have been engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Weill Cornell Medicine's powerful network of collaborators extends to its parent university Cornell University; to Qatar, where Weill Cornell Medicine-Qatar offers a Cornell University medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medicine faculty provide comprehensive patient care at NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian Lower Manhattan Hospital, NewYork-Presbyterian Queens and NewYork-Presbyterian Brooklyn Methodist Hospital. Weill Cornell Medicine is also affiliated with Houston Methodist.
Dr. Harel Weinstein, chairman of physiology and biophysics and the Maxwell M. Upson Professor of Physiology and Biophysics, has been elected to the American Physiological Society’s 2019 Class of Fellows. A rank of fellow in the society is an elite member status reserved to honor distinguished leaders who have demonstrated excellence in science, have made significant contributions to physiological sciences and related disciplines, and have served the society.
Dr. Lisa Newman, chief of the section of breast surgery at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, was elected second vice president of the American College of Surgeons during the Clinical Congress in San Francisco. As second vice president, Dr. Newman will, in the absence or inability of the president and first vice-president to act, preside at all college meetings, perform the duties and exercise the powers of the president and be invited to attend all meetings of the Board of Regents except executive sessions.
Dr. Lewis C. Cantley, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, has been named a 2019 winner of the Horwitz Prize, awarded for work on a critical cancer pathway. Dr. Cantley's laboratory discovered the PI3K signaling pathway in the mid-1980s. His team showed that PI3K triggers cells to take up glucose in response to insulin and other growth factors and traced the cascade of molecular signals that interact with PI3K to control cell growth.